Walter Paul Weber
Overview
Explore the profile of Walter Paul Weber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
1875
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kurzeder C, Nguyen-Strauli B, Krol I, Ring A, Castro-Giner F, Nuesch M, et al.
Nat Med
. 2025 Jan;
PMID: 39856336
The presence of circulating tumor cell (CTC) clusters is associated with disease progression and reduced survival in a variety of cancer types. In breast cancer, preclinical studies showed that inhibitors...
2.
Daster K, Hench J, Diepenbruck M, Volkmann K, Rouchon A, Palafox M, et al.
Breast Cancer Res Treat
. 2024 Oct;
209(2):389-396.
PMID: 39392573
Purpose: Most triple-negative breast cancers (TNBC) are sporadic in nature and often associated with dysfunction of the BRCA1 or BRCA2 genes. Since somatic BRCA mutations are rare in breast cancer...
3.
Heidinger M, Egle D, Piscuoglio S, Navarro-Aguadero M, Sanchez S, Hergueta-Redondo M, et al.
Anticancer Res
. 2024 Jun;
44(7):2981-2988.
PMID: 38925824
Background/aim: Extracellular vesicle DNA (EV-DNA) has emerged as a novel biomarker for tumor mutation detection using liquid biopsies, exhibiting biological advantages compared to cell-free DNA (cfDNA). This study assessed the...
4.
Weber W, Hanson S, Wong D, Heidinger M, Montagna G, Cafferty F, et al.
Am Soc Clin Oncol Educ Book
. 2024 May;
44(3):e438776.
PMID: 38815195
The management of axillary lymph nodes in breast cancer is continually evolving. Recent data now support omitting axillary lymph node dissection (ALND) in most patients with metastases in up to...
5.
Grasic Kuhar C, Geiger J, Schwab F, Heinzelmann-Schwartz V, Vetter M, Weber W, et al.
Cancers (Basel)
. 2024 Apr;
16(7).
PMID: 38610984
Neoadjuvant systemic treatment (NST) is the standard treatment for HER2+, triple-negative (TN), and highly proliferative luminal HER2- early breast cancer. Pathologic complete response (pCR) after NST is associated with improved...
6.
Landin J, Weber W, Vetter M
Ther Umsch
. 2023 Nov;
80(8):353-358.
PMID: 37971525
Breast cancer today has a significantly better prognosis than two to three decades ago. Treatment options have improved significantly. However, new systemic therapy has also resulted in side effects that...
7.
Kaidar-Person O, Pfob A, Gentilini O, Borisch B, Bosch A, Cardoso M, et al.
EClinicalMedicine
. 2023 Aug;
61:102085.
PMID: 37528842
Clinical axillary lymph node management in early breast cancer has evolved from being merely an aspect of surgical management and now includes the entire multidisciplinary team. The second edition of...
8.
Tausch C, Daster K, Hayoz S, Matrai Z, Fitzal F, Henke G, et al.
Breast Cancer Res Treat
. 2023 Jun;
201(2):215-225.
PMID: 37355526
Purpose: The aim of this study was to evaluate clinical practice heterogeneity in use of neoadjuvant systemic therapy (NST) for patients with clinically node-positive breast cancer in Europe. Methods: The...
9.
Banys-Paluchowski M, Kuhn T, Masannat Y, Rubio I, de Boniface J, Ditsch N, et al.
Cancers (Basel)
. 2023 Feb;
15(4).
PMID: 36831516
Background: Surgical excision of a non-palpable breast lesion requires a localization step. Among available techniques, wire-guided localization (WGL) is most commonly used. Other techniques (radioactive, magnetic, radar or radiofrequency-based, and...
10.
Diamantopoulou Z, Castro-Giner F, Schwab F, Foerster C, Saini M, Budinjas S, et al.
Nature
. 2022 Jun;
607(7917):156-162.
PMID: 35732738
The metastatic spread of cancer is achieved by the haematogenous dissemination of circulating tumour cells (CTCs). Generally, however, the temporal dynamics that dictate the generation of metastasis-competent CTCs are largely...